+ Translate

Benefit-cost analysis and simulation models: tools in the decision making process whether starting a vaccination programme or not

, : Benefit-cost analysis and simulation models: tools in the decision making process whether starting a vaccination programme or not. Acta Veterinaria Scandinavica. Supplementum 90: 17-24

A critical account is given of cost benefit analysis for the evaluation of vaccination programmes.

(PDF 0-2 workdays service)

Accession: 002763826

PMID: 8996884

Submit PDF Full Text: Here

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:

Related references

Bernknopf Richard L.; Davis James F.; Sutter John F.; Soller David R., 1997: Developing tools for decision making under uncertainty; integrating predictive earth science models with probabilistic cost-benefit analysis. Policy initiatives and incentives to reduce losses from future environmental hazards (changes)can be analyzed in a framework within which benefits and costs are identified and evaluated from society's perspective. Application of cost-benefit...

Inoue, Y.; Sakurai, T., 1992: Tools for supporting the decision making process of clinical laboratory use. Decision analysis. Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 93: 83-93

Paulsen, H., 2002: With the computer against erosion. Simulation models help with decision making and cost reduction. Data inputs used for the computer model Erosion-3D are digital relief, precipitation, soil type, soil particle size distribution, organic carbon content, tillage and data from geographic information systems. The model detects areas with potential...

Preblud, S.R.; Orenstein, W.A.; Koplan, J.P.; Bart, K.J.; Hinman, A.R., 1985: A benefit-cost analysis of a childhood varicella vaccination programme. We examined the expected experience of normal individuals from a hypothetical birth cohort of 3.5 million persons followed from birth to their 30th birthday without and with a varicella vaccination programme. We assumed that one dose of vaccine wo...

Pauker, S.G.; Kassirer, J.P., 1975: Therapeutic decision making: a cost-benefit analysis. To help the physician decide whether or not to treat a patient who may or may not have a disease, a method has been developed for calculating a therapeutic threshold. If the probability of disease in a given patient exceeds the threshold, the pref...

Crandall, R.W., 1981: The use of cost-benefit analysis in regulatory decision-making. Annals of the New York Academy of Sciences 363: 99-107

Ajmal Waheed, 2000: Cost-benefit analysis (CBA): a useful technique for rational decision making. The paper examines the strengths and particularly some problem areas that militate against the effective implementation of CBA in the project planning and evaluation. The first part has set the stage by describing the CBA concept. It has been foun...

Ginsberg, G.M.; Kassis, I.; Dagan, R., 1993: Cost benefit analysis of Haemophilus influenzae type b vaccination programme in Israel. The recent availability of Haemophilus influenzae type b (HIB) conjugate vaccines prompted an examination of the costs and benefits of four and three dose HIB prevention programmes targeting all newborns in Israel. A four dose programme would redu...

Hutton, J., 1992: Cost-benefit analysis in health care expenditure decision-making. Health Economics 1(4): 213-216

Thornbury, J.R.; Fryback, D.G., 1977: Cost-benefit analysis, medical decision making and the individual radiologist. Current Problems in Diagnostic Radiology 7(2): 1-35